KATHRYN E FALBERG Insider Trading $RCUS Arcus Biosciences, Inc.
Get free email notifications about insider trading for KATHRYN E FALBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KATHRYN E FALBERG. KATHRYN E FALBERG is Director in HUMAN GENOME SCIENCES INC ($HGSI) and Director in MEDIVATION, INC. ($MDVN) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Director in aTYR PHARMA INC ($LIFE) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and Director in Aimmune Therapeutics, Inc. ($AIMT) and Director in Axovant Sciences Ltd. ($AXON) and Director in Trade Desk, Inc. ($TTD) and Director in UroGen Pharma Ltd. ($URGN) and Director in Arcus Biosciences, Inc. ($RCUS) and Director in Nuvation Bio Inc. ($PANA).
KATHRYN E FALBERG in Arcus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 102,106 shares
Latest Transaction: Apr 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KATHRYN E FALBERG in Arcus Biosciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, RCUS, LIFE, BMRN, GYHT, HGSI, MDVN, NUVB, AXON, TTD, TCDA, URGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | P | 28.35 | 20,000 | 566,996 | 102,106 | 82.1 K to 102.1 K (+24.36 %) |
| Jun 08 2020 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Option Exercise | A | 30.05 | 14,000 | 420,700 | 14,000 | |
| Jun 08 2020 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 3,000 | 0 | 83,504 | 80.5 K to 83.5 K (+3.73 %) |
| Jun 14 2019 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | P | 8.52 | 12,935 | 110,152 | 82,106 | 69.2 K to 82.1 K (+18.70 %) |
| Jun 13 2019 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | P | 8.49 | 10,000 | 84,928 | 69,171 | 59.2 K to 69.2 K (+16.90 %) |
| Jun 13 2019 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | P | 7.90 | 10,000 | 79,000 | 59,171 | 49.2 K to 59.2 K (+20.34 %) |
| Jun 11 2019 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | P | 8.25 | 10,000 | 82,500 | 49,171 | 39.2 K to 49.2 K (+25.53 %) |
| Jun 11 2019 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | P | 7.99 | 22,065 | 176,297 | 39,171 | 17.1 K to 39.2 K (+128.99 %) |
| Jun 10 2019 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Option Exercise | A | 7.99 | 35,000 | 279,650 | 35,000 | |
| Mar 19 2018 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Option Exercise | C | 0.00 | 17,106 | 0 | 0 | |
| Mar 19 2018 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | P | 15.00 | 30,000 | 450,000 | 80,504 | 50.5 K to 80.5 K (+59.40 %) |
| Mar 19 2018 | RCUS | Arcus Biosciences, ... | FALBERG KATHRYN E | Director | Buy | C | 0.00 | 17,106 | 0 | 17,106 | 0 to 17.1 K |
Page: 1